Cargando…

Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma

PURPOSE: To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T(2)-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). METHODS: Using a retrospective patient cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Booth, Thomas C., Larkin, Timothy J., Yuan, Yinyin, Kettunen, Mikko I., Dawson, Sarah N., Scoffings, Daniel, Canuto, Holly C., Vowler, Sarah L., Kirschenlohr, Heide, Hobson, Michael P., Markowetz, Florian, Jefferies, Sarah, Brindle, Kevin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435159/
https://www.ncbi.nlm.nih.gov/pubmed/28520730
http://dx.doi.org/10.1371/journal.pone.0176528
_version_ 1783237182245306368
author Booth, Thomas C.
Larkin, Timothy J.
Yuan, Yinyin
Kettunen, Mikko I.
Dawson, Sarah N.
Scoffings, Daniel
Canuto, Holly C.
Vowler, Sarah L.
Kirschenlohr, Heide
Hobson, Michael P.
Markowetz, Florian
Jefferies, Sarah
Brindle, Kevin M.
author_facet Booth, Thomas C.
Larkin, Timothy J.
Yuan, Yinyin
Kettunen, Mikko I.
Dawson, Sarah N.
Scoffings, Daniel
Canuto, Holly C.
Vowler, Sarah L.
Kirschenlohr, Heide
Hobson, Michael P.
Markowetz, Florian
Jefferies, Sarah
Brindle, Kevin M.
author_sort Booth, Thomas C.
collection PubMed
description PURPOSE: To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T(2)-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). METHODS: Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort. RESULTS: The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T(2)-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression. CONCLUSION: Analysis of heterogeneity, in T(2)-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.
format Online
Article
Text
id pubmed-5435159
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54351592017-05-26 Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma Booth, Thomas C. Larkin, Timothy J. Yuan, Yinyin Kettunen, Mikko I. Dawson, Sarah N. Scoffings, Daniel Canuto, Holly C. Vowler, Sarah L. Kirschenlohr, Heide Hobson, Michael P. Markowetz, Florian Jefferies, Sarah Brindle, Kevin M. PLoS One Research Article PURPOSE: To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T(2)-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). METHODS: Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort. RESULTS: The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T(2)-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression. CONCLUSION: Analysis of heterogeneity, in T(2)-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required. Public Library of Science 2017-05-17 /pmc/articles/PMC5435159/ /pubmed/28520730 http://dx.doi.org/10.1371/journal.pone.0176528 Text en © 2017 Booth et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Booth, Thomas C.
Larkin, Timothy J.
Yuan, Yinyin
Kettunen, Mikko I.
Dawson, Sarah N.
Scoffings, Daniel
Canuto, Holly C.
Vowler, Sarah L.
Kirschenlohr, Heide
Hobson, Michael P.
Markowetz, Florian
Jefferies, Sarah
Brindle, Kevin M.
Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title_full Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title_fullStr Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title_full_unstemmed Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title_short Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
title_sort analysis of heterogeneity in t(2)-weighted mr images can differentiate pseudoprogression from progression in glioblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435159/
https://www.ncbi.nlm.nih.gov/pubmed/28520730
http://dx.doi.org/10.1371/journal.pone.0176528
work_keys_str_mv AT booththomasc analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT larkintimothyj analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT yuanyinyin analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT kettunenmikkoi analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT dawsonsarahn analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT scoffingsdaniel analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT canutohollyc analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT vowlersarahl analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT kirschenlohrheide analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT hobsonmichaelp analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT markowetzflorian analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT jefferiessarah analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma
AT brindlekevinm analysisofheterogeneityint2weightedmrimagescandifferentiatepseudoprogressionfromprogressioninglioblastoma